Spring Mountain Capital is a growth equity investment firm established in 2001 and located in New York, New York. The firm specializes in providing expansion capital to companies that are leveraging breakthrough innovations, paradigm shifts, or significant market changes. It focuses on sectors within the U.S. economy that exhibit the highest growth potential, including enterprise software, technology-enabled services, digital health, and healthcare services. Additionally, Spring Mountain Capital shows a preference for investments in life sciences, cybersecurity, e-commerce, impact investing, and virtual reality. As a Registered Investment Adviser, the firm is dedicated to fostering the development of companies that are positioned to thrive in rapidly evolving markets.
Yunu is a med-tech company that has created a platform aimed at enhancing access to clinical trial and experimental data for researchers and healthcare professionals globally. This platform integrates medical imaging insights and facilitates communication between radiologists and oncologists, while also linking cross-site study teams, sponsors, core laboratories, contract research organizations, and off-site clinical resources. By promoting collaboration within the healthcare sector, Yunu seeks to improve data integrity and accelerate the development of therapies, making them more accessible to patients.
Hiveclass
Seed Round in 2025
Hiveclass is a developer of a digital content mobile platform focused on transforming youth sports training and physical education. The company provides a variety of original, athlete-led training videos across multiple sports and fitness activities, such as basketball, soccer, volleyball, tennis, dance, and self-defense. This platform encourages children to engage in physical activities, promoting play, running, and jumping while facilitating connections with other athletes. Through its content, Hiveclass aims to help young sports enthusiasts learn new techniques, master tricks, and enjoy their athletic pursuits.
Wingtra
Series B in 2024
Wingtra AG, founded in 2014 and based in Zürich, Switzerland, specializes in the manufacture of professional drones, notably the WingtraOne, a vertical take-off and landing (VTOL) UAV. This drone is designed for high-precision data collection and has applications across various industries, including surveying, agriculture, forestry, and infrastructure management. Since its market introduction in 2017, Wingtra has established partnerships with over 50 major surveying equipment dealers globally, facilitating the adoption of its technology. The WingtraOne can be operated using WingtraPilot software, enabling users to collect survey-grade aerial data that can be transformed into two-dimensional maps and three-dimensional models, thereby enhancing monitoring and inspection capabilities in sectors such as construction, mining, and environmental management.
Thentia Cloud
Series B in 2024
Thentia Corporation specializes in providing innovative technology solutions to assist regulatory bodies in efficiently meeting their obligations. The company offers a comprehensive platform that serves as a secure and user-friendly tool for regulators, along with a cost-effective cloud-based product designed for private businesses. This dual approach enables both regulatory agencies and companies to enhance their compliance and governance practices. By leveraging industry expertise and advanced software, Thentia aims to promote regulatory excellence and streamline processes for clients across Canada and the United States.
showd.me
Series A in 2023
Showd.me is an enterprise peer-to-peer learning platform designed to facilitate employee training and development within organizations. The platform enables employees to share knowledge and skills through various cross-platform tools, including keyword skill search, chat, video, file sharing, and email integration. This approach allows for efficient onboarding of new hires, development of employee expertise, and the identification of potential career paths. Additionally, Showd.me offers online compliance training, particularly in healthcare, which supports remote and on-demand learning. By providing a comprehensive suite of training and professional development services, Showd.me helps organizations reduce in-service costs while enhancing employee capabilities.
ProSomnus Sleep Technologies
Post in 2023
ProSomnus Sleep Technologies is a medical device manufacturer based in Pleasanton, California, specializing in precision oral appliance therapy devices for the treatment of obstructive sleep apnea. Established in 2016, the company focuses on developing intraoral devices that enhance patient compliance, comfort, and treatment effectiveness. Its flagship products, the ProSomnus [IA] and MicrO2 Sleep and Snore Devices, provide a more comfortable and less invasive alternative to traditional continuous positive airway pressure therapy. By addressing the needs of both patients and dentists, ProSomnus aims to improve patient experiences and outcomes in managing obstructive sleep apnea, a condition that affects over 74 million Americans and is linked to serious health issues such as heart failure and diabetes.
Rayleigh Acoustics
Series A in 2023
Rayleigh Acoustics is an audio product design company that offers design solutions including ID, acoustics, structure, hardware, and software.
Recess
Series A in 2022
Recess operates as an experiential partnership marketing platform that facilitates connections between brands and consumers through event and venue partnerships across the United States. The company provides an online platform that allows brands to discover, book, and execute marketing activations at various events, particularly targeting college students through partnerships with universities. Founded in 2013 and headquartered in Marina del Rey, California, Recess offers a comprehensive solution for advertisers, enabling them to engage and acquire new customers efficiently. The platform streamlines the process of executing experiential partnerships, allowing users to manage logistics, contracts, and payments while measuring the return on investment. Additionally, Recess organizes music and ideas festivals that foster collaboration among entrepreneurs, startups, and artists, further enhancing its role in the event marketing landscape.
Vergent Bioscience
Series B in 2022
Vergent Bioscience, Inc. specializes in developing tumor-targeted fluorescent probes that enhance the surgical removal of cancerous tissue. Founded in 2013 and based in Minneapolis, Minnesota, the company’s flagship product, VGT-309, is a molecularly-targeted imaging molecule designed to bind to enzymes overexpressed in various tumor tissues. Upon injection before surgery, VGT-309 activates a brightly fluorescing dye, enabling surgeons to visually distinguish cancerous tissue from normal tissue during procedures. This technology aims to improve surgical outcomes by ensuring the complete removal of tumors, which is crucial for increasing cure rates. Vergent Bioscience's innovative approach addresses a significant clinical need for advanced visualization in various surgical settings, including open, laparoscopic, and robotic surgeries.
Thentia Cloud
Series B in 2022
Thentia Corporation specializes in providing innovative technology solutions to assist regulatory bodies in efficiently meeting their obligations. The company offers a comprehensive platform that serves as a secure and user-friendly tool for regulators, along with a cost-effective cloud-based product designed for private businesses. This dual approach enables both regulatory agencies and companies to enhance their compliance and governance practices. By leveraging industry expertise and advanced software, Thentia aims to promote regulatory excellence and streamline processes for clients across Canada and the United States.
Genomenon
Series B in 2022
Genomenon, Inc. is a software development company based in Ann Arbor, Michigan, that specializes in tools for genetic diagnosis and discovery. Founded in 2014, it provides a suite of diagnostic and discovery solutions that enable physicians, researchers, and pharmaceutical companies to rapidly and accurately identify disease-causing variants from genomic sequencing data. The company’s flagship product, GENOMENON, automates the analysis of next-generation sequencing data, thereby enhancing decision-making processes in clinical settings and accelerating discoveries in genomics. With its focus on improving cancer diagnosis and treatment, Genomenon aims to support better patient outcomes through its innovative software solutions.
EverWash
Series B in 2022
EverWash Car Club is a technology-driven company specializing in the car wash industry through its mobile-powered Membership Sales and Subscription Management Platform. The company operates a cloud-based subscription management platform that automates the entire process of membership sales, marketing, and management. This includes customer enrollment, billing, and revenue recognition. By providing a user-friendly mobile application, EverWash allows customers to easily find, purchase, and manage their monthly car wash memberships securely from their smartphones. This innovative approach helps car wash operators achieve significant revenue growth while enhancing customer retention and operational efficiency.
Eyrus
Series A in 2022
Eyrus is a workforce visibility platform tailored for the construction industry, focusing on automating the collection of workforce data to improve various operational aspects such as attendance, timekeeping, safety, and security. By implementing Eyrus during workforce registration, project teams can easily capture essential information regarding OSHA compliance, health and safety training, and equipment qualifications through user-friendly worker profiles. Utilizing IoT and mobile technology, Eyrus enables real-time monitoring of workforce interactions on job sites, enhancing access control and providing timely alerts during emergencies. The platform also offers compliance reporting metrics and analytics that aid in schedule forecasting, helping to identify potential delays and improve decision-making and project planning. Overall, Eyrus delivers actionable insights that enhance resource management, project safety, and efficiency in commercial construction.
Koneksa
Series C in 2022
Koneksa Health Inc. is a healthcare data analytics company focused on enhancing clinical studies and disease research through the use of remotely generated patient data. The company's software, Koneksa Compare, facilitates the collection, visualization, and analysis of patient-generated data, incorporating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires. This platform allows pharmaceutical and biotech companies, as well as academic researchers, to make informed decisions and regulatory claims based on objective data. Koneksa also provides biometric devices that generate electronic clinical outcome assessments and offers a dashboard for monitoring patient engagement, which includes reminders for study subjects. Founded in 2013 and headquartered in New York, Koneksa has an additional office in London, United Kingdom.
Ankyra
Series B in 2021
Ankyra is a biotechnology company focused on developing anchored immunotherapy for cancer treatment. The company addresses the limitations of traditional cytokine therapies, which are often restricted due to widespread immune activation and associated toxicity. Ankyra's innovative approach involves the use of its Anchored Immunotherapy Platform to create ANK-101, a stable complex of a modified IL-12 cytokine and aluminum hydroxide, an FDA-approved adjuvant. This combination allows for targeted intratumoral delivery, enhancing the localized retention and activity of IL-12 while reducing systemic side effects. By optimizing the therapeutic potential of anchored immunotherapy, Ankyra aims to improve treatment outcomes for cancer patients, offering a safer and more effective alternative to conventional therapies.
Aware
Series C in 2021
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.
Lessonbee
Seed Round in 2021
Lessonbee Inc. is an online learning platform focused on health and wellness education for students in grades K-12. Founded in 2017 and headquartered in Mount Vernon, New York, the company provides a cloud-based reflective learning system that includes adaptive lessons and a shared content library. This platform allows educators to access current and relevant educational content, manage student assignments, and foster engagement through regular reflection. Lessonbee emphasizes culturally responsive and medically accurate health education, equipping students with the knowledge and skills to promote healthy living. Additionally, it utilizes proprietary analytics to assess student health goals and school climate, recommending tailored content from a diverse library of self-paced classes, adaptive courses, and video-based lessons that align with state and national health education standards. The platform aims to enhance personalized health education and support social-emotional learning for students both at home and in school.
RepairSmith
Series B in 2021
RepairSmith is a company that offers convenient car repair and maintenance services. Car owners can choose to have their repairs done at their own driveway or drop off their vehicle at the company's shop. They provide upfront pricing, online booking, after-hours support, and a full warranty for their services. RepairSmith's mechanics are equipped with company vehicles and professional tools, and are trained to prioritize customer satisfaction.
Allyx Therapeutics
Venture Round in 2021
Allyx Therapeutics, founded in 2018 and based in Durham, Connecticut, is a clinical-stage biotechnology company focused on developing disease-modifying treatments for Alzheimer's Disease. The company’s primary product is an orally bioavailable small molecule that functions as a silent allosteric modulator of mGluR5. This innovative drug aims to reverse neurodegeneration and offers a potential approach to preserve cognitive function in patients with Alzheimer's. By targeting the underlying mechanisms of the disease, Allyx Therapeutics strives to provide effective therapeutic solutions for those affected by neurodegenerative disorders.
Thentia Cloud
Series B in 2021
Thentia Corporation specializes in providing innovative technology solutions to assist regulatory bodies in efficiently meeting their obligations. The company offers a comprehensive platform that serves as a secure and user-friendly tool for regulators, along with a cost-effective cloud-based product designed for private businesses. This dual approach enables both regulatory agencies and companies to enhance their compliance and governance practices. By leveraging industry expertise and advanced software, Thentia aims to promote regulatory excellence and streamline processes for clients across Canada and the United States.
Aware
Series B in 2020
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.
Koneksa
Series B in 2020
Koneksa Health Inc. is a healthcare data analytics company focused on enhancing clinical studies and disease research through the use of remotely generated patient data. The company's software, Koneksa Compare, facilitates the collection, visualization, and analysis of patient-generated data, incorporating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires. This platform allows pharmaceutical and biotech companies, as well as academic researchers, to make informed decisions and regulatory claims based on objective data. Koneksa also provides biometric devices that generate electronic clinical outcome assessments and offers a dashboard for monitoring patient engagement, which includes reminders for study subjects. Founded in 2013 and headquartered in New York, Koneksa has an additional office in London, United Kingdom.
Maven Clinic
Series C in 2020
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
IsoPlexis
Series C in 2020
IsoPlexis is a life science technology company based in Branford, Connecticut, founded in 2013. It focuses on developing a single-cell detection system that identifies patient immune responses at the single-cell level. This innovative platform enables the assessment of therapeutic safety and efficacy, as well as the monitoring of disease progression. IsoPlexis specializes in cell-based proteomic systems and biomarkers, providing insights into functional protein biology and cellular signaling networks with high resolution. By offering these capabilities, the company aids in predicting patient responses to novel immunotherapies and cellular therapies, ultimately enhancing therapeutic development and informing clinical decisions.
IsoPlexis
Series C in 2019
IsoPlexis is a life science technology company based in Branford, Connecticut, founded in 2013. It focuses on developing a single-cell detection system that identifies patient immune responses at the single-cell level. This innovative platform enables the assessment of therapeutic safety and efficacy, as well as the monitoring of disease progression. IsoPlexis specializes in cell-based proteomic systems and biomarkers, providing insights into functional protein biology and cellular signaling networks with high resolution. By offering these capabilities, the company aids in predicting patient responses to novel immunotherapies and cellular therapies, ultimately enhancing therapeutic development and informing clinical decisions.
Keen Decision Systems
Series A in 2019
Keen Decision Systems, LLC is a software developer based in Durham, North Carolina, specializing in marketing measurement and optimization platforms. Founded in 2010, the company offers a software-as-a-service solution that empowers marketers to make informed, data-driven decisions. Its technology provides real-time insights into the financial contributions of various marketing channels, enabling users to maximize profitability and revenue while effectively managing their marketing investments. By helping marketers understand when to allocate or withdraw spending, Keen Decision Systems supports businesses in adapting to market changes and strategizing future actions.
Maven Clinic
Series B in 2018
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
RiskSense
Series B in 2018
RiskSense, Inc. specializes in cyber risk management solutions, offering a cloud-based platform that enables organizations to assess and manage their cybersecurity risks effectively. The RiskSense Platform allows users to evaluate their cyber risk exposure across a broad attack surface, orchestrate remediation efforts, and monitor outcomes. Key services include RiskSense Vulnerability Discovery, which provides regular vulnerability assessments to identify security weaknesses, and RiskSense Attack Surface Validation, which assesses vulnerabilities that could be exploited by cyber adversaries. The platform employs risk-based scoring and analytics to present a comprehensive view of cybersecurity risks, allowing organizations to prioritize remediation activities based on critical security weaknesses. Founded in 2006 and headquartered in Sunnyvale, California, RiskSense also has offices in Albuquerque, New Mexico, and India.
Vergent Bioscience
Series A in 2018
Vergent Bioscience, Inc. specializes in developing tumor-targeted fluorescent probes that enhance the surgical removal of cancerous tissue. Founded in 2013 and based in Minneapolis, Minnesota, the company’s flagship product, VGT-309, is a molecularly-targeted imaging molecule designed to bind to enzymes overexpressed in various tumor tissues. Upon injection before surgery, VGT-309 activates a brightly fluorescing dye, enabling surgeons to visually distinguish cancerous tissue from normal tissue during procedures. This technology aims to improve surgical outcomes by ensuring the complete removal of tumors, which is crucial for increasing cure rates. Vergent Bioscience's innovative approach addresses a significant clinical need for advanced visualization in various surgical settings, including open, laparoscopic, and robotic surgeries.
ReNetX Bio
Series A in 2018
ReNetX Bio, Inc. is a biotechnology company focused on developing therapeutics for injuries and damage to the central nervous system (CNS). Its primary product, Nogo Trap, is a decoy receptor that binds to growth inhibitors, facilitating the natural growth of nerve fibers and promoting processes such as axonal regeneration, axonal sprouting, and synaptic plasticity. The company's treatments address various CNS conditions, including spinal cord injury, stroke recovery, and glaucoma. Additionally, ReNetX Bio is involved in developing disease-modifying therapeutics aimed at conditions like Alzheimer's disease, utilizing small molecule oral compounds that inhibit the binding of β-amyloid oligomers in the brain. Founded in 2009 and based in New Haven, Connecticut, the company was previously known as Axerion Therapeutics, Inc. before rebranding in July 2017.
Home Captain
Series A in 2018
Home Captain Inc. is a technology-driven real estate company based in New York, founded in 2013. It offers a comprehensive platform that connects home buyers and sellers with local real estate agents, enhancing the overall customer experience in the property market. The company provides a suite of services, including a web and mobile MLS-integrated home search app, AI-powered chat support, and concierge services to assist clients throughout the buying and selling process. Additionally, Home Captain features agent screening and management tools, as well as a patent-pending technology for matching clients with suitable agents. The platform also offers specialized services for veterans, providing competitive interest rate quotes and tailored guidance to help them navigate the complexities of homeownership. By integrating these tools and services, Home Captain aims to streamline real estate transactions and support mortgage lenders in maintaining customer relationships.
180 Health Partners
Series B in 2018
180 Health Partners, Inc. is a healthcare provider focused on addressing substance use and behavioral health challenges, particularly among expecting mothers. The company offers a program known as The 180 Way, which combines personalized interdisciplinary treatment with a supportive ecosystem. This program is complemented by the StrongWell initiative, designed to assist pregnant women in overcoming addiction and ensuring the delivery of healthy babies. 180 Health Partners facilitates multi-modal care coordination, connecting opioid-addicted mothers with healthcare providers to receive medical assistance in their preferred settings, including home, doctor's offices, or through virtual consultations. Established in 2016 and headquartered in Franklin, Tennessee, the company is dedicated to improving health outcomes for mothers and their children.
IsoPlexis
Series B in 2017
IsoPlexis is a life science technology company based in Branford, Connecticut, founded in 2013. It focuses on developing a single-cell detection system that identifies patient immune responses at the single-cell level. This innovative platform enables the assessment of therapeutic safety and efficacy, as well as the monitoring of disease progression. IsoPlexis specializes in cell-based proteomic systems and biomarkers, providing insights into functional protein biology and cellular signaling networks with high resolution. By offering these capabilities, the company aids in predicting patient responses to novel immunotherapies and cellular therapies, ultimately enhancing therapeutic development and informing clinical decisions.
Maven Clinic
Series A in 2017
Maven Clinic is an on-demand digital care clinic focused on supporting mothers and families during conception, pregnancy, and the postpartum period. Founded in 2014 and headquartered in New York City, the clinic provides video appointments and private messaging with a network of women's and family health practitioners. Its comprehensive services cater to various needs, including IVF and egg-freezing tracks, pregnancy, postpartum, partner support, adoption, surrogacy, and loss. Additionally, Maven Clinic offers career coaching, support, and customized training for human resources managers. The company serves individuals, employers, and healthcare professionals, aiming to enhance family health and well-being through accessible digital care solutions.
SimpleReach
Series B in 2017
SimpleReach, Inc. provides a platform that tracks social interaction with published content to deliver insights and performance metrics related to social behavior. By integrating data from various channels and websites, the company offers a comprehensive view of content effectiveness, helping clients enhance their return on content investments. Utilizing advanced machine learning and artificial intelligence, SimpleReach assists marketers in refining future campaigns and enables publishers to create dashboards for monitoring and reporting on campaign performance. The company serves a range of clients, including notable brands like Intel, Chase, and Home Depot, who rely on its platform to gain actionable insights and improve content impact. Founded in 2010 and based in New York, SimpleReach operates as a subsidiary of Nativo, Inc. since March 2019.
Doctor.com
Series A in 2017
Doctor.com is a healthcare marketing automation platform designed specifically for healthcare organizations to improve the digital patient experience. The company provides a range of services, including reputation management, patient acquisition, and online scheduling, all aimed at enhancing the visibility and credibility of healthcare providers. Its proprietary network connects to numerous consumer health and local business sites, allowing clients to reach over 100 million patients each month. By integrating data management and patient communication tools, Doctor.com helps healthcare organizations build trust with patients and streamline their operations, positioning itself as a leader in the healthcare SaaS sector. As one of the fastest-growing companies in this niche, it is supported by a skilled team and notable investors.
Prevalent
Series B in 2016
Prevalent, Inc. specializes in third-party risk management software and services designed to help organizations mitigate security and compliance risks associated with vendors and suppliers throughout the third-party lifecycle. Founded in 2004 and headquartered in Phoenix, Arizona, Prevalent offers a range of solutions, including Vendor Risk Manager, which assesses vendor risk based on their significance to the organization, and Vendor Threat Monitor, which tracks various risk areas such as data and operational risks. The company also provides a Policy Portal for governance management and a Legal Vendor Network aimed at law firms for monitoring third-party security risks. Prevalent's offerings include compliance services tailored to meet global regulatory requirements, as well as professional services like vulnerability assessments and incident management. Additionally, the firm operates networks specific to sectors like healthcare, ensuring robust security and privacy measures are in place. With offices in multiple locations, including the U.S. and the U.K., Prevalent operates as a subsidiary of iMedX, Inc.
Oncoceutics
Series A in 2015
Oncoceutics, Inc. is a clinical-stage drug discovery and development company based in Philadelphia, Pennsylvania, founded in 2009. The company focuses on developing therapeutics that target critical signaling pathways in cancer. Its lead compound, ONC201, is an orally active DRD2 small molecule antagonist known for its significant anti-tumor activity across various cancer types through a unique mechanism of action. ONC201 has demonstrated compelling preclinical efficacy and a favorable safety profile, making it a promising candidate for clinical use. The company is actively conducting clinical trials for ONC201 at leading cancer centers globally, aiming to provide safe and effective treatment options for patients with advanced cancers. Additionally, Oncoceutics maintains strategic alliances with organizations such as the National Institutes of Health and Calvert Research, LLC, to enhance its research and development efforts.
Ziften
Series C in 2015
Ziften is a privately funded endpoint security company located in Austin, Texas. It specializes in providing a cloud-delivered endpoint protection platform that safeguards various endpoints, including laptops, desktops, servers, and cloud environments. Ziften's platform offers advanced protection, endpoint detection and response, and security posture analysis, enabling organizations to effectively manage and secure their applications and processes across both physical and virtual Windows environments. By focusing on simplifying endpoint protection, Ziften helps businesses defend their documents and critical assets against cyber attacks.
Activate Healthcare
Venture Round in 2015
Activate Healthcare, LLC operates healthcare clinics that focus on providing proactive and preventive primary care services. Founded in 2009 and headquartered in Indianapolis, Indiana, with an additional office in Chicago, the company delivers care for a variety of conditions, including respiratory infections, gastrointestinal disorders, and minor injuries. It also offers preventive services such as wellness exams, health screenings, and chronic condition management for issues like hypertension and diabetes. In addition, Activate Healthcare provides occupational health services addressing repetitive injuries and substance abuse testing. The company primarily serves government organizations, schools, and businesses in manufacturing and transportation sectors. By utilizing predictive modeling tools, Activate Healthcare aims to engage patients in managing their health proactively, thereby reducing health risks and improving overall wellness. As of January 2019, Activate Healthcare operates as a subsidiary of Paladina Health, LLC.
OpenSlate
Series A in 2015
OpenSlate is a leading provider of brand safety and contextual analytics for digital video content. Founded in 2012 by CEO Mike Henry and headquartered in New York, the company specializes in measuring the brand suitability of online content for advertisers. OpenSlate's platform offers advertisers targeted solutions that ensure alignment with appropriate content, rather than merely tracking exposure to potentially unsuitable material. Utilizing predictive data science, OpenSlate generates actionable metrics that assess the nature and quality of content across various platforms, particularly focused on YouTube but applicable to all digital video. The company serves every major advertising holding company and some of the largest global advertisers, helping them identify the most effective content for their advertising campaigns.
Oncoceutics
Venture Round in 2014
Oncoceutics, Inc. is a clinical-stage drug discovery and development company based in Philadelphia, Pennsylvania, founded in 2009. The company focuses on developing therapeutics that target critical signaling pathways in cancer. Its lead compound, ONC201, is an orally active DRD2 small molecule antagonist known for its significant anti-tumor activity across various cancer types through a unique mechanism of action. ONC201 has demonstrated compelling preclinical efficacy and a favorable safety profile, making it a promising candidate for clinical use. The company is actively conducting clinical trials for ONC201 at leading cancer centers globally, aiming to provide safe and effective treatment options for patients with advanced cancers. Additionally, Oncoceutics maintains strategic alliances with organizations such as the National Institutes of Health and Calvert Research, LLC, to enhance its research and development efforts.
Activate Healthcare
Private Equity Round in 2014
Activate Healthcare, LLC operates healthcare clinics that focus on providing proactive and preventive primary care services. Founded in 2009 and headquartered in Indianapolis, Indiana, with an additional office in Chicago, the company delivers care for a variety of conditions, including respiratory infections, gastrointestinal disorders, and minor injuries. It also offers preventive services such as wellness exams, health screenings, and chronic condition management for issues like hypertension and diabetes. In addition, Activate Healthcare provides occupational health services addressing repetitive injuries and substance abuse testing. The company primarily serves government organizations, schools, and businesses in manufacturing and transportation sectors. By utilizing predictive modeling tools, Activate Healthcare aims to engage patients in managing their health proactively, thereby reducing health risks and improving overall wellness. As of January 2019, Activate Healthcare operates as a subsidiary of Paladina Health, LLC.
IsoPlexis
Series A in 2014
IsoPlexis is a life science technology company based in Branford, Connecticut, founded in 2013. It focuses on developing a single-cell detection system that identifies patient immune responses at the single-cell level. This innovative platform enables the assessment of therapeutic safety and efficacy, as well as the monitoring of disease progression. IsoPlexis specializes in cell-based proteomic systems and biomarkers, providing insights into functional protein biology and cellular signaling networks with high resolution. By offering these capabilities, the company aids in predicting patient responses to novel immunotherapies and cellular therapies, ultimately enhancing therapeutic development and informing clinical decisions.
HμREL
Series A in 2013
HμREL® Corporation is an early-stage bioanalytic tools company with operations based in Kenilworth and New Brunswick, New Jersey, USA. Robert Freedman serves as Chief Executive Officer. Martin Yarmush is the Company’s Chief Scientific Adviser.
WhipTail
Series C in 2012
WhipTail Technologies commercialized the first all-flash enterprise storage array to address performance issues in data centers. Installed worldwide in numerous mission critical database, virtualization, and online environments, WhipTail's solid-state storage dramatically reduces delays related to hard disk contention and access times, allowing servers to process more data in dramatically less time -- months to days, hours to minutes. Since 2009, customers have relied on WhipTail's flash-based arrays for extreme IOPS, bandwidth and latency, optimizing performance of key business functions and bringing modern performance demanding applications to life.
OpenSlate
Series A in 2012
OpenSlate is a leading provider of brand safety and contextual analytics for digital video content. Founded in 2012 by CEO Mike Henry and headquartered in New York, the company specializes in measuring the brand suitability of online content for advertisers. OpenSlate's platform offers advertisers targeted solutions that ensure alignment with appropriate content, rather than merely tracking exposure to potentially unsuitable material. Utilizing predictive data science, OpenSlate generates actionable metrics that assess the nature and quality of content across various platforms, particularly focused on YouTube but applicable to all digital video. The company serves every major advertising holding company and some of the largest global advertisers, helping them identify the most effective content for their advertising campaigns.
WhipTail
Series B in 2012
WhipTail Technologies commercialized the first all-flash enterprise storage array to address performance issues in data centers. Installed worldwide in numerous mission critical database, virtualization, and online environments, WhipTail's solid-state storage dramatically reduces delays related to hard disk contention and access times, allowing servers to process more data in dramatically less time -- months to days, hours to minutes. Since 2009, customers have relied on WhipTail's flash-based arrays for extreme IOPS, bandwidth and latency, optimizing performance of key business functions and bringing modern performance demanding applications to life.
WhipTail
Series A in 2011
WhipTail Technologies commercialized the first all-flash enterprise storage array to address performance issues in data centers. Installed worldwide in numerous mission critical database, virtualization, and online environments, WhipTail's solid-state storage dramatically reduces delays related to hard disk contention and access times, allowing servers to process more data in dramatically less time -- months to days, hours to minutes. Since 2009, customers have relied on WhipTail's flash-based arrays for extreme IOPS, bandwidth and latency, optimizing performance of key business functions and bringing modern performance demanding applications to life.
NXTM
Private Equity Round in 2011
Led by a former senior MTV executive, NXTM powers the digital presence for superstars Taylor Swift, Justin Timberlake, and Lenny Kravitz. Via its platform WHOOZNXT, NXTM equips emerging artists with these same tools and top-tier exposure opportunities. With major media partnerships in television, radio, live venues, digital platforms, and more - WHOOZNXT is the only platform that rewards the online activity of artists with real-world exposure.
Coolerado
Series B in 2010
Coolerado Corporation specializes in the design, manufacture, and marketing of energy-efficient air conditioning systems for light commercial and residential applications. Founded in 2004 and headquartered in Denver, Colorado, the company utilizes proprietary and patented technology to create air conditioning solutions that significantly reduce energy consumption. Coolerado's product line includes heat and mass exchangers, compact modular air conditioners, and energy recovery ventilators, which serve a diverse range of sectors such as data centers, schools, healthcare, retail, and government. With a focus on improving indoor air quality while minimizing carbon emissions, Coolerado caters to customers through a network of dealers worldwide. As of June 2015, Coolerado operates as a subsidiary of Seeley International Pty Ltd.
Perquest
Series B in 2007
Perquest is a provider of web-based payroll services tailored for smaller employers, offering a comprehensive suite of full-service payroll and SaaS-based human resources, benefits, and time management applications. The company focuses on redefining workforce solutions through technology and innovative service processes, emphasizing a strong service culture throughout its organization. By integrating advanced customer relationship management technology, Perquest ensures transparency and responsiveness, allowing clients to receive timely support through a secure client portal. Their commitment to reliability and user-friendly solutions makes it easier for mid-sized companies to manage their workforce needs effectively, leveraging a single platform that combines essential payroll functions with robust HR capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.